Human Monkeypox: Current State of Knowledge and Implications for the Future
Top Cited Papers
Open Access
- 20 December 2016
- journal article
- review article
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 1 (1), 8
- https://doi.org/10.3390/tropicalmed1010008
Abstract
The zoonosis human monkeypox (MPX) was discovered in 1970, twelve years after the discovery of monkeypox virus (MPXV) in a Danish laboratory in 1958. Historically confined to West Africa (WA) and the Congo basin (CB), new epidemics in Sudan and the United States of America (USA) have fuelled new research highlighting environmental factors contributing to the expanded geographical spread of monkeypox virus (MPXV). A systematic literature review was conducted in MEDLINE® (Ovid), MEDLINE® (PubMed) and Google Scholar databases using the search terms: monkeypox, MPXV and “human monkeypox”. The literature revealed MPX has classic prodromal symptoms followed by a total body rash. The sole distinguishing clinical characteristic from other pox-like illnesses is the profound lymphadenopathy. Laboratory diagnosis of MPX is essential, a suitable test for endemic areas is under development but not yet available. For the time being anti-poxvirus antibodies in an unvaccinated individual with a history of severe illness and rash can suggest MPX infection. The reservoir host remains elusive yet the rope squirrel and Gambian pouched rat appear to be the most likely candidates. Transmission includes fomite, droplet, direct contact with infected humans or animals and consumption of infected meat. Though smallpox vaccination is protective against MPXV, new non-immune generations contribute to increasing incidence. Environmental factors are increasing the frequency of contact with potential hosts, thus increasing the risk of animal-to-human transmission. Increased risk of transmission through globalisation, conflict and environmental influences makes MPX a more realistic threat to previously unaffected countries. Health worker training and further development and accessibility of suitable diagnostic tests, vaccinations and anti-viral treatment is becoming increasingly necessary.Keywords
This publication has 54 references indexed in Scilit:
- Pathogen-Host Associations and Predicted Range Shifts of Human Monkeypox in Response to Climate Change in Central AfricaPLOS ONE, 2013
- Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected SubjectsThe Journal of Infectious Diseases, 2012
- Assessing the Effectiveness of a Community Intervention for Monkeypox Prevention in the Congo BasinPLoS Neglected Tropical Diseases, 2011
- Using Remote Sensing to Map the Risk of Human Monkeypox Virus in the Congo BasinEcohealth, 2010
- Development of ST-246® for Treatment of Poxvirus InfectionsViruses, 2010
- Human Monkeypox Outbreak Caused by Novel Virus Belonging to Congo Basin Clade, Sudan, 2005Emerging Infectious Diseases, 2010
- Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of CongoProceedings of the National Academy of Sciences of the United States of America, 2010
- Monkeypox: An epidemiologic and clinical comparison of African and US diseaseJournal of the American Academy of Dermatology, 2006
- Outbreak of Human Monkeypox, Democratic Republic of Congo, 1996 to 1997Emerging Infectious Diseases, 2001